Joosten, Leo A. B. http://orcid.org/0000-0001-6166-9830
Crişan, Tania O.
Bjornstad, Petter
Johnson, Richard J. http://orcid.org/0000-0003-3312-8193
Article History
Accepted: 29 October 2019
First Online: 10 December 2019
Competing interests
: R.J.J. declares that he is an inventor on several patents and patent applications related to the role of fructose and urate metabolism in hypertension, metabolic syndrome and kidney disease. He also has equity with XORTX therapeutics, which is developing novel xanthine oxidase inhibitors, and Colorado Research Partners LLC, which is developing inhibitors of fructose metabolism. Finally, he has received honoraria from Astra Zeneca, Eli Lilly and Horizon Pharmaceuticals. P.B. declares that he has received consulting fees or speaking honoraria or both from Horizon Pharma, Boehringer Ingelheim, Bayer, and Bristol-Myers Squibb. He also serves on a scientific advisory board for XORTX Therapeutics. L.A.B.J. and T.O.C. declare that they have no competing interests.